BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9184233)

  • 21. Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors.
    Billin AN; Eilers AL; Queva C; Ayer DE
    J Biol Chem; 1999 Dec; 274(51):36344-50. PubMed ID: 10593926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.
    Grinberg AV; Hu CD; Kerppola TK
    Mol Cell Biol; 2004 May; 24(10):4294-308. PubMed ID: 15121849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular recognition in helix-loop-helix and helix-loop-helix-leucine zipper domains. Design of repertoires and selection of high affinity ligands for natural proteins.
    Ciarapica R; Rosati J; Cesareni G; Nasi S
    J Biol Chem; 2003 Apr; 278(14):12182-90. PubMed ID: 12514181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.
    Ayer DE; Eisenman RN
    Genes Dev; 1993 Nov; 7(11):2110-9. PubMed ID: 8224841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional regulation. Flipping the Myc switch.
    Bernards R
    Curr Biol; 1995 Aug; 5(8):859-61. PubMed ID: 7583141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative splicing and embryonic expression of the Xenopus mad4 bHLH gene.
    Newman CS; Krieg PA
    Dev Dyn; 1999 Jun; 215(2):170-8. PubMed ID: 10373021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.
    Zervos AS; Gyuris J; Brent R
    Cell; 1993 Jan; 72(2):223-32. PubMed ID: 8425219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia.
    Guo XL; Pan L; Zhang XJ; Suo XH; Niu ZY; Zhang JY; Wang F; Dong ZR; Da W; Ohno R
    Leuk Lymphoma; 2007 Jun; 48(6):1200-7. PubMed ID: 17577784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of transcriptional repression by max homodimers.
    Yin X; Grove L; Prochownik EV
    Oncogene; 1998 May; 16(20):2629-37. PubMed ID: 9632139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.
    Lafita-Navarro MC; Liaño-Pons J; Quintanilla A; Varela I; Blanco R; Ourique F; Bretones G; Aresti J; Molina E; Carroll P; Hurlin P; Romero OA; Sanchez-Céspedes M; Eisenman RN; Delgado MD; León J
    J Biol Chem; 2020 Feb; 295(7):2001-2017. PubMed ID: 31919096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic in vivo interactions among Myc network members.
    Yin X; Landay MF; Han W; Levitan ES; Watkins SC; Levenson RM; Farkas DL; Prochownik EV
    Oncogene; 2001 Aug; 20(34):4650-64. PubMed ID: 11498788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the Max-binding protein MNT in human medulloblastomas.
    Sommer A; Waha A; Tonn J; Sörensen N; Hurlin PJ; Eisenman RN; Lüscher B; Pietsch T
    Int J Cancer; 1999 Sep; 82(6):810-6. PubMed ID: 10446446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
    Desbarats L; Gaubatz S; Eilers M
    Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo.
    James L; Eisenman RN
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10429-34. PubMed ID: 12149476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
    Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP
    Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ.
    Beaulieu ME; McDuff FO; Frappier V; Montagne M; Naud JF; Lavigne P
    J Mol Recognit; 2012 Jul; 25(7):414-26. PubMed ID: 22733550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity.
    Ayer DE; Kretzner L; Eisenman RN
    Cell; 1993 Jan; 72(2):211-22. PubMed ID: 8425218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19.
    Edelhoff S; Ayer DE; Zervos AS; Steingrímsson E; Jenkins NA; Copeland NG; Eisenman RN; Brent R; Disteche CM
    Oncogene; 1994 Feb; 9(2):665-8. PubMed ID: 8290278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The crystal structure of an intact human Max-DNA complex: new insights into mechanisms of transcriptional control.
    Brownlie P; Ceska T; Lamers M; Romier C; Stier G; Teo H; Suck D
    Structure; 1997 Apr; 5(4):509-20. PubMed ID: 9115440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biophysical and Structural Methods to Study the bHLHZip Region of Human c-MYC.
    Zinzalla G
    Methods Mol Biol; 2021; 2318():21-43. PubMed ID: 34019285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.